Feldan Therapeutics
4 known investors
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.
Founders & leadership
FM
François-Thomas MichaudinBoard Member & Chief Executive Officer
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BSep 2024
Fonds de solidarité FTQ (lead), Genesys Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Feldan Therapeutics do?
- Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.
- Who are Feldan Therapeutics's investors?
- Feldan Therapeutics's investors include Genesys Capital, Linearis Ventures, Fonds de solidarité FTQ, Zynext Ventures.